Impaired vascular dilatation in women with a history of pre-eclampsia

Objective The mechanisms underlying increased cardiovascular risk among women with a history of pre-eclampsia remain unclear. Impaired endothelial function has been observed in both pre-eclampsia and atherosclerosis, and provides a plausible link between the two conditions. We studied endothelial function and arterial compliance in non-pregnant, previously pre-eclamptic women. Design A study of 30 women with a history of pre-eclampsia and 21 women with a previous normotensive, uncomplicated pregnancy was carried out. Methods Changes in brachial artery blood flow, induced by intra-arterial infusions of an endothelium-independent (sodium nitroprusside) and an endothelium-dependent (acetylcholine) vasodilator, were measured by venous occlusion plethysmography. Arterial stiffness was assessed by pulse-wave analysis. Results Vasodilatation was impaired in women with previous pre-eclampsia; at low and high concentrations of endothelium-independent (P = 0.004 and P = 0.057, respectively) and endothelium-dependent (P = 0.045 and P = 0.02) vasodilators, respectively. There was no difference in arterial stiffness between the groups (P = 0.45). In multiple regression analyses both endothelium-independent and endothelium-dependent vasodilatations were independently associated with a history of pre-eclampsia and parity. There was no correlation with blood pressure, body mass index (BMI), smoking or age. Conclusions The finding of impaired vascular dilatation several years after a pre-eclamptic pregnancy could contribute to the higher risk of cardiovascular disease in these women.

[1]  N. Sattar,et al.  Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy? , 2004, Atherosclerosis.

[2]  Lewis H Kuller,et al.  Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk. , 2004, American journal of physiology. Heart and circulatory physiology.

[3]  V. Hiilesmaa,et al.  Risk for subsequent coronary artery disease after preeclampsia. , 2004, The American journal of cardiology.

[4]  A. Hingorani,et al.  Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia , 2003, The Lancet.

[5]  G. Prescott,et al.  Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study , 2003, BMJ : British Medical Journal.

[6]  L. Bowyer,et al.  Forearm blood flow in pre‐eclampsia , 2003, BJOG : an international journal of obstetrics and gynaecology.

[7]  J. Cutler,et al.  Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy , 2003, Hypertension in pregnancy.

[8]  L. Lind,et al.  Evaluation of four different methods to measure endothelium-dependent vasodilation in the human peripheral circulation. , 2002, Clinical science.

[9]  J. A. Rodríguez-Feo,et al.  Reduction of the soluble cyclic GMP vasorelaxing system in the vascular wall of stroke-prone spontaneously hypertensive rats: effect of the α1-receptor blocker doxazosin , 2002, Journal of hypertension.

[10]  R. Touyz.  Impaired vasorelaxation in hypertension: beyond the endothelium. , 2002, Journal of hypertension.

[11]  David J. Webb,et al.  Pulse‐Wave Analysis: Clinical Evaluation of a Noninvasive, Widely Applicable Method for Assessing Endothelial Function , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[12]  D. Webb,et al.  Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications. , 2001, British journal of clinical pharmacology.

[13]  J. Pell,et al.  Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129 290 births , 2001, The Lancet.

[14]  J. Gamble,et al.  A longitudinal study of resting peripheral blood flow in normal pregnancy and pregnancies complicated by chronic hypertension and pre-eclampsia. , 2001, Cardiovascular research.

[15]  J. Kooner,et al.  Association of maternal endothelial dysfunction with preeclampsia. , 2001, JAMA.

[16]  P. Chowienczyk,et al.  Assessment of forearm vasodilator responses to acetylcholine and albuterol by strain gauge plethysmography: reproducibility and influence of strain gauge placement. , 2001, British journal of clinical pharmacology.

[17]  Jm Roberts,et al.  Pathogenesis and genetics of pre-eclampsia , 2001, The Lancet.

[18]  M. Taskinen,et al.  Endothelial dysfunction in men with small LDL particles. , 2000, Circulation.

[19]  L. Weissfeld,et al.  Dyslipoproteinaemia in postmenopausal women with a history of eclampsia , 2000, BJOG : an international journal of obstetrics and gynaecology.

[20]  D. Webb,et al.  The influence of heart rate on augmentation index and central arterial pressure in humans , 2000, The Journal of physiology.

[21]  R. Boys,et al.  Nitric oxide activity in the peripheral vasculature during normotensive and preeclamptic pregnancy. , 1999, The American journal of physiology.

[22]  H. Laivuori,et al.  Evidence of a state of increased insulin resistance in preeclampsia. , 1999, Metabolism: clinical and experimental.

[23]  K. Sørensen,et al.  Normal pregnancy is associated with enhanced endothelium-dependent flow-mediated vasodilation. , 1999, American journal of physiology. Heart and circulatory physiology.

[24]  I. Sargent,et al.  Preeclampsia: an excessive maternal inflammatory response to pregnancy. , 1999, American journal of obstetrics and gynecology.

[25]  D. Webb,et al.  Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis , 1998, Journal of hypertension.

[26]  C. H. Chen,et al.  Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function. , 1997, Circulation.

[27]  S. Ferry,et al.  Cardiovascular sequelae of toxaemia of pregnancy. , 1997, Heart.

[28]  M. O'Rourke,et al.  Pulse wave analysis. , 1996, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[29]  R. Schmieder,et al.  Preeclampsia -- a state of sympathetic overactivity. , 1996, The New England journal of medicine.

[30]  H. Laivuori,et al.  Hyperinsulinemia 17 years after preeclamptic first pregnancy. , 1996, The Journal of clinical endocrinology and metabolism.

[31]  R. Arngrímsson,et al.  Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. , 1996, Acta obstetricia et gynecologica Scandinavica.

[32]  C. Hubel.  Fasting serum triglycerides, free fatty acids and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours postpartum. , 1996 .

[33]  R. Evans,et al.  Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum. , 1996, American journal of obstetrics and gynecology.

[34]  P Hjemdahl,et al.  Biochemical assessment of sympathetic activity and prejunctional modulation of noradrenaline release in humans. , 1996, Journal of hypertension.

[35]  R. Arngrímsson,et al.  Death rates from ischemic heart disease in women with a history of hypertension in pregnancy , 1995 .

[36]  P Vallance,et al.  Measuring forearm blood flow and interpreting the responses to drugs and mediators. , 1995, Hypertension.

[37]  J. Duvekot,et al.  Maternal Cardiovascular Hemodynamic Adaptation to Pregnancy , 1994, Obstetrical & gynecological survey.

[38]  James M. Roberts,et al.  Preeclampsia: More Than Pregnancy‐Induced Hypertension , 1994 .

[39]  James M. Roberts,et al.  Pre-eclampsia: more than pregnancy-induced hypertension , 1993, The Lancet.

[40]  L. Poston,et al.  Abnormal endothelial cell function of resistance arteries from women with preeclampsia. , 1993, American journal of obstetrics and gynecology.

[41]  Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. , 2000, American journal of obstetrics and gynecology.

[42]  D. Webb,et al.  Pulse wave analysis and arterial stiffness. , 1998, Journal of cardiovascular pharmacology.